Dosage and administration
Apply as needed.
Apply as needed.
Monistat Care Chafing Relief Powder Gel®
Drug Facts
Dimethicone 1.2%
Skin Protectant
For external use only.
do not get into eyes.
If swallowed get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Apply as needed.
Store at 20˚-25˚C (68˚-77˚F)
cyclomethicone, dimethicone, dimethicone/vinyl dimethicone crosspolymer, silica dimethyl silylate, vinyl dimethicone/methicone silsesquioxane crosspolymer
1-877-666-4782 Monistat.com
MONISTAT
Care®
Chafing Relief Powder Gel®
DIMETHICONE /SKIN PROTECTANT
NET WT/ Peso Neto 1.5 oz (42g)
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 706952 | dimethicone 1.2 % Topical Gel | PSN | 5 |
| 1117398 | MONISTAT COMPLETE CARE Chafing Relief 1.2 % Topical Gel | PSN | 5 |
| 1117398 | dimethicone 0.012 MG/MG Topical Gel [Monistat Soothing Care] | SBD | 5 |
| 706952 | dimethicone 0.012 MG/MG Topical Gel | SCD | 5 |
| 706952 | dimethicone 1.2 % Topical Gel | SY | 5 |
| 1117398 | Monistat Soothing Care 0.012 MG/MG Topical Gel | SY | 5 |
| 1117398 | Monistat Soothing Care Chafing Relief 1.2 % Topical Gel | SY | 5 |
| Class | Version | Type | Effective |
|---|---|---|---|
| DIMETHICONE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63736-031-01 | Monistat Complete Care Chafing Relief | 42 g in 1 TUBE | GEL | 42 | 5 | |
| 63736-031-01 | Monistat Complete Care Chafing Relief | 1 in 1 CARTON | GEL | 1 | 5 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| dimethicone | ACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| dimethicone | ACTIVE MOIETY | 92RU3N3Y1O | 1 | |
| .alpha.-tocopherol acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| dimethicone/vinyl dimethicone crosspolymer (hard particle) | INACTIVE INGREDIENT | H895X08VNQ | 1 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| trisiloxane | INACTIVE INGREDIENT | 9G1ZW13R0G | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63736-031 | 63736-031-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIMETHICONE | 92RU3N3Y1O | ACTIB |
| CYCLOMETHICONE 5 | 0THT5PCI0R | IACT |
| DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) | 9E4CO0W6C5 | IACT |
| SILICA DIMETHYL SILYLATE | EU2PSP0G0W | IACT |
| VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER | 9NH1UDD2RR | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| .alpha.-tocopherol acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | CREAM, AUGMENTED / TOPICAL | 260 mg | ||
| cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL, FOAM / TOPICAL | 144 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| .alpha.-tocopherol acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| .alpha.-tocopherol acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| .alpha.-tocopherol acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL, FOAM / TOPICAL | 144 mg | ||
| cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| .alpha.-tocopherol acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | AEROSOL / TOPICAL | 2.5 %w/w | ||
| .alpha.-tocopherol acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| cyclomethicone 5 | CYCLOMETHICONE 5 | 0THT5PCI0R | CREAM, AUGMENTED / TOPICAL | 260 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Monistat Complete Care Chafing Relief | DIMETHICONE | Insight Pharmaceuticals LLC | 07d7c883-1fa3-4786-905c-a1fab649765e | 2024-04-19 | Warnings | 63736-031-01 63736-031 63736003101 7298c9c8-609a-4f1e-967b-faf2d183aa77 07d7c883-1fa3-4786-905c-a1fab649765e |
Adverse event summaries are temporarily unavailable. Other product information remains available.